Akanda Corp. (AKAN)
NASDAQ: AKAN · IEX Real-Time Price · USD
0.441
-0.015 (-3.21%)
At close: Dec 29, 2023, 4:00 PM
0.461
+0.021 (4.70%)
After-hours: Dec 29, 2023, 7:35 PM EST
Company Description
Akanda Corp., through its subsidiaries, engages in the cultivation, manufacture, and distribution of cannabis products to patients worldwide.
The company operates through Cultivation and Distribution segments. It intends to supply medicinal-grade cannabis and cannabis based medical and wellness products.
The company was founded in 2018 and is headquartered in New Romney, the United Kingdom.
Akanda Corp.
Country | United Kingdom |
Founded | 2021 |
IPO Date | Mar 15, 2022 |
Industry | Drug Manufacturers - Specialty & Generic |
Sector | Healthcare |
Employees | 46 |
CEO | Ms. Katharyn Field |
Contact Details
Address: 1a, 1b Learoyd Road New Romney, X0 TN28 8XU United Kingdom | |
Phone | 442034889514 |
Website | akandacorp.com |
Stock Details
Ticker Symbol | AKAN |
Exchange | NASDAQ |
Fiscal Year | January - December |
Reporting Currency | USD |
IPO Price | $4.00 |
CIK Code | 0001888014 |
CUSIP Number | 00971M106 |
ISIN Number | CA00971M2058 |
SIC Code | 2833 |
Key Executives
Name | Position |
---|---|
Louisa Madiako Mojela B.Com., B.Comm | Executive Chairman |
Tejinder Virk | Chief Executive Officer and Director |
Trevor W. Scott BAcc, BCom (Hons), CA(SA) | Chief Financial Officer and Secretary |
Thomas Flow | Chief Operating Officer |
Latest SEC Filings
Date | Type | Title |
---|---|---|
Dec 29, 2023 | 6-K | Report of foreign issuer |
Dec 12, 2023 | 6-K | Report of foreign issuer |
Oct 25, 2023 | SC 13G | Statement of acquisition of beneficial ownership by individuals |
Sep 25, 2023 | 6-K | Report of foreign issuer |
Sep 20, 2023 | 6-K | Report of foreign issuer |
Aug 18, 2023 | 6-K | Report of foreign issuer |
Jul 14, 2023 | S-8 | Securities to be offered to employees in employee benefit plans |
Jul 6, 2023 | 6-K | Report of foreign issuer |
May 30, 2023 | 6-K | Report of foreign issuer |
May 16, 2023 | 144 | Filing |